Skip to content


You currently have no items in your basket.


Sciomics is active in the early-phase development of novel diagnostic means for precision medicine with a focus on cancer as well as organ failure. These activities are based on an immunobased platform for highly multiplex protein analysis developed by the founders at the German Cancer Research Center (DKFZ) during the past 15 years.


To view our range of products, click here

View Products

This website uses cookies. For more information about these please click here.
By continuing to browse you consent to the use of cookies